CLINICAL TRIALS PROFILE FOR ANGELIQ
✉ Email this page to a colleague
All Clinical Trials for Angeliq
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00102141 ↗ | Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women | Completed | Bayer | Phase 3 | 2004-04-01 | The objective of the study is to evaluate the effects of Angeliq on BP over a period of 8 weeks in postmenopausal women who may benefit from hormone replacement therapy (HRT) for the relief of vasomotor symptoms and who have hypertension. |
| NCT00185328 ↗ | Efficacy and Tolerability of Angeliq in Thai Women | Completed | Bayer | Phase 4 | 2005-09-01 | To evaluate the safety, tolerability, and efficacy of Angeliq in Thai post menopausal women with hot flushes and other climacteric symptoms. |
| NCT00356447 ↗ | Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms. | Completed | Bayer | Phase 3 | 2006-05-01 | The study evaluates in Chinese post-menopausal women the combination of drospirenone 2 mg and estradiol 1 mg for the treatment of climacteric symptoms, such as hot flushes (vasomotor symptoms) and uro-genital complaints. |
| NCT00420342 ↗ | Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension | Completed | Bayer | Phase 2 | 2007-01-01 | The main purpose of this study is to compare the effects of treatment of two different formulations of Angeliq® and Prempro on blood pressure in post-menopausal women with prehypertension. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Angeliq
Condition Name
Clinical Trial Locations for Angeliq
Trials by Country
Clinical Trial Progress for Angeliq
Clinical Trial Phase
Clinical Trial Sponsors for Angeliq
Sponsor Name
